Post–COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user

Monika Skrzypiec‐Spring; Justyna Kuliczkowska-Płaksej; Adam Szeląg; Marek Bolanowski

doi:10.1186/s12879-025-12144-2

December 9, 2025BMC Infectious DiseasesOpen Access

Post–COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user

View Full Paper

Ask AI

Bookmark

Share

Key Points

This report aims to highlight the occurrence of subacute thyroiditis in the context of post-COVID-19 complications.
Case report of a patient with unexplained thyrotoxicosis
Detailed history of anabolic steroid use
Clinical evaluation and follow-up
Subacute thyroiditis diagnosed after COVID-19 infection
Identification of anabolic steroid use as a confounding factor
Patient exhibited typical symptoms of thyroiditis

Implication

Case report reveals subacute thyroiditis in a patient with thyrotoxicosis post-COVID-19, suggesting effects of anabolic steroids.

Abstract

This case highlights the need to consider subacute thyroiditis in patients with unexplained thyrotoxicosis after COVID-19, especially when confounding factors, such as anabolic steroid use, are present.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Skrzypiec‐Spring et al. (2025) studied this question.

synapsesocial.com/papers/69401efa2d562116f28f9930 https://doi.org/10.1186/s12879-025-12144-2

View Full Paper

Ask AI

Bookmark

Share

Post–COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user

Key Points

Implication

Abstract

Discussion

Cite This Study

Post–COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading